Related Experiment Video

Updated: Jul 25, 2026

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment
10:59

Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment

Published on: November 23, 2017

Possible role of accessibility of protein-SH groups to the cancer state

F E Knock

    Archiv Fur Geschwulstforschung
    |January 1, 1981
    PubMed

    Insights

    Protein-sulfhydryl (SH) groups are crucial in cancer development and treatment. SH inhibitors show promise as anticancer agents, potentially improving cancer therapy by targeting specific patient sensitivities.

    Area of Science:

    • Biochemistry
    • Oncology
    • Cell Biology

    Background:

    • Protein-sulfhydryl (SH) groups are predominantly located in the nucleus and nuclear membranes.
    • SH groups play a significant role in the cancerous state.

    Purpose of the Study:

    • To investigate the role of protein-SH groups in cancer.
    • To evaluate the efficacy of SH inhibitors as anticancer agents.
    • To explore the potential of SH inhibitors in cancer immunotherapy and diagnostics.

    Main Methods:

    • Histochemical studies to identify protein-SH group localization.
    • Clinical and sensitivity tests comparing SH inhibitors with conventional anticancer agents.
    • Animal studies to assess the immunogenic and cellular effects of SH inhibitors.
    • Electron Spin Resonance (ESR) spectroscopy to analyze SH inhibitor and glyoxal derivative effects on cancer signals.

    Main Results:

    • SH inhibitors demonstrate greater activity against various cancers compared to normal tissues.
    • SH inhibitors can induce anticancer immunity in animals and alter cancer cell surface morphology.
    • SH inhibitors and glyoxal derivatives can normalize low ESR signals in cancers.
    • Protein-SH group accessibility and variable reactivity are key factors in cancer.

    Conclusions:

    • Protein-SH groups are vital to cancer, suggesting targeted therapies are necessary.
    • SH inhibitors offer a promising therapeutic strategy due to their selective action and immunomodulatory effects.
    • Current randomized cancer therapy protocols may be invalid as they do not account for individual cancer chemical sensitivities.

    More Related Videos

    A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions09:00

    A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

    Published on: April 18, 2025

    Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools07:01

    Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

    Published on: August 19, 2025

    Related Concept Videos

    Protein Networks02:26

    Protein Networks

    An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
    These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    Cancer-Critical Genes I: Proto-oncogenes01:33

    Cancer-Critical Genes I: Proto-oncogenes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...